What is Trimas's 2027?

Trimas (TRS) reported 2027 of $750K in Q1 2026.

How has Trimas's 2027 changed year-over-year?

Trimas's 2027 increased by 31.6% year-over-year, from $570K to $750K.

What is the long-term trend for Trimas's 2027?

Over 2 years (2023 to 2025), Trimas's 2027 has grown at a 9.7% compound annual growth rate (CAGR), from $540K to $650K.

Trimas TRS 2027

2027 at other companies

West Pharmaceutical ServicesWST

——

Chart IndustriesGTLS

——

Other financials

Income statement

See full

Revenue$168.3M+10.4%

Gross profit$36.9M+12.3%

Operating income$6.9M-3.6%

Net income$800.8M+6,348%

EPS (diluted)$21.40+7,033%

Balance sheet

See full

Cash & equivalents$1.3B+3,904%

Total debt$439.9M-9.2%

Total equity$1.4B+111%

Total assets$2.3B+64.8%

Cash flow

See full

Operating cash flow-$19.4M-311%

CapEx$5.2M-59.7%

Free cash flow-$24.6M-556%

Valuation

See full

Market cap$1.56B+41.9%

Enterprise value$692.33M-65.6%

P/E1.7×-33.2×

P/S2.4×+0.6×

Profitability

See full

Gross margin-0.1%-2.1pp

Operating margin8%-1.0pp

Net margin137.3%+132pp

FCF margin7.3%+3.1pp

Returns & leverage

See full

Return on equity85.1%+80.4pp

Debt / equity0.3×-0.4×

Current ratio4.9×+2.0×

Where this comes from

Reported directly by Trimas in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths.

The official record: Trimas’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Trimas's 2027.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Trimas's 2027?: Trimas (TRS) reported 2027 of $750K in Q1 2026.
How has Trimas's 2027 changed year-over-year?: Trimas's 2027 increased by 31.6% year-over-year, from $570K to $750K.
What is the long-term trend for Trimas's 2027?: Over 2 years (2023 to 2025), Trimas's 2027 has grown at a 9.7% compound annual growth rate (CAGR), from $540K to $650K.